These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28604554)

  • 21. Autoimmune hypophysitis.
    Ileana-Dumbrava E; Subbiah V
    Lancet Oncol; 2018 Feb; 19(2):e123. PubMed ID: 29413466
    [No Abstract]   [Full Text] [Related]  

  • 22. Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab.
    Martens A; Wistuba-Hamprecht K; Geukes Foppen M; Yuan J; Postow MA; Wong P; Romano E; Khammari A; Dreno B; Capone M; Ascierto PA; Di Giacomo AM; Maio M; Schilling B; Sucker A; Schadendorf D; Hassel JC; Eigentler TK; Martus P; Wolchok JD; Blank C; Pawelec G; Garbe C; Weide B
    Clin Cancer Res; 2016 Jun; 22(12):2908-18. PubMed ID: 26787752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of ipilimumab for treating advanced melanoma: A systematic review and meta-analysis.
    Li J; Gu J
    J Clin Pharm Ther; 2019 Jun; 44(3):420-429. PubMed ID: 30693536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune meningoencephalitis in a melanoma patient treated with ipilimumab.
    Choe JH; Andonian BJ; Kim GJ; Salama AK
    Immunotherapy; 2016 Oct; 8(10):1163-7. PubMed ID: 27605066
    [No Abstract]   [Full Text] [Related]  

  • 25. The Mayo Clinic Experience With the Neurological Complications of the CTLA-4 Inhibitor Ipilimumab.
    Ruff MW; Mauermann ML
    Neurologist; 2018 May; 23(3):98-99. PubMed ID: 29722744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of a patient with HIV and metastatic melanoma with consequitive ipilimumab and nivolumab.
    Tomsitz D; Hein R; Biedermann T; Kohlmeyer J
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e26-e28. PubMed ID: 28662283
    [No Abstract]   [Full Text] [Related]  

  • 27. Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma.
    Petrella TM; Robert C; Richtig E; Miller WH; Masucci GV; Walpole E; Lebbe C; Steven N; Middleton MR; Hille D; Zhou W; Ibrahim N; Cebon J
    Eur J Cancer; 2017 Nov; 86():115-124. PubMed ID: 28987768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report of Ipilimumab-Induced Diffuse, Nonnecrotizing Granulomatous Lymphadenitis and Granulomatous Vasculitis.
    Arellano K; Mosley JC; Moore DC
    J Pharm Pract; 2018 Apr; 31(2):227-229. PubMed ID: 29279030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors.
    Arangalage D; Delyon J; Lermuzeaux M; Ekpe K; Ederhy S; Pages C; Lebbé C
    Ann Intern Med; 2017 Nov; 167(9):683-684. PubMed ID: 28869988
    [No Abstract]   [Full Text] [Related]  

  • 30. Flexible Sigmoidoscopy Rather than Colonoscopy Is Adequate for the Diagnosis of Ipilimumab-Associated Colitis.
    Herlihy JD; Beasley S; Simmelink A; Maddukuri V; Amin A; Kamionek M; Jacobs C; Bossi K; Scobey M
    South Med J; 2019 Mar; 112(3):154-158. PubMed ID: 30830228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma.
    Changizzadeh PN; Mukkamalla SKR; Armenio VA
    J Immunother Cancer; 2017 Dec; 5(1):97. PubMed ID: 29254501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma.
    Bottlaender L; Breton AL; de Laforcade L; Dijoud F; Thomas L; Dalle S
    J Immunother Cancer; 2017 Jul; 5(1):57. PubMed ID: 28716106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ipilimumab-associated halo-like inflammatory reactions around nevi during therapy for metastatic melanoma.
    Alniemi DT; Fischer A; Greene LA; Pierson JC
    Dermatol Online J; 2018 Jul; 24(7):. PubMed ID: 30261564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypophysitis and other autoimmune complications related to immune checkpoints inhibitors´ treatment: Spectrum of imaging appearances.
    Malikova H; Holesta M; Fialova A; Arenbergerova M; Weichet J
    Neuro Endocrinol Lett; 2018 Sep; 39(3):196-204. PubMed ID: 30431741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulomatous Reaction in a Patient With Metastatic Melanoma Treated With Ipilimumab: First Case Reported With Isolated Cutaneous Findings.
    Cervantes J; Rosen A; Dehesa L; Dickinson G; Alonso-Llamazares J
    Actas Dermosifiliogr (Engl Ed); 2019; 110(1):43-49. PubMed ID: 30389125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders.
    Kähler KC; Eigentler TK; Gesierich A; Heinzerling L; Loquai C; Meier F; Meiss F; Pföhler C; Schlaak M; Terheyden P; Thoms KM; Ziemer M; Zimmer L; Gutzmer R;
    Cancer Immunol Immunother; 2018 May; 67(5):825-834. PubMed ID: 29487980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Case of Acute Exacerbation of Chronic Adrenal Insufficiency Due to Ipilimumab Treatment for Advanced Melanoma.
    Sakaguchi C; Yano S; Ashida K; Wada N; Ohe K; Nagata H; Matsuda Y; Sakamoto S; Sakamoto R; Ohnaka K; Uchi H; Furue M; Nomura M; Ogawa Y
    Am J Case Rep; 2019 Jan; 20():106-110. PubMed ID: 30679413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A fatal case of Immune thrombocytopenia secondary to the immune checkpoint inhibitor ipilimumab in a patient with BRAF wild type metastatic melanoma.
    Hadfield MJ; Mui G
    J Oncol Pharm Pract; 2020 Sep; 26(6):1530-1532. PubMed ID: 32063108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case of metastatic uveal melanoma in which an antitumor effect appeared after ipilimumab discontinuation due to autoimmune hypophysitis.
    Ohnuma T; Matsuzawa T; Kinoshita M; Sano S; Kawamura T; Shimada S; Inozume T
    J Dermatol; 2017 Nov; 44(11):1325-1326. PubMed ID: 27864834
    [No Abstract]   [Full Text] [Related]  

  • 40. Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma.
    Liao B; Shroff S; Kamiya-Matsuoka C; Tummala S
    Neuro Oncol; 2014 Apr; 16(4):589-93. PubMed ID: 24482447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.